S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 91 TWD 1.11% Market Closed
Market Cap: 10.9B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

Operating Margin
SCI Pharmtech Inc

11.3%
Current
13%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.3%
=
Operating Profit
159.9m
/
Revenue
1.4B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
TW
SCI Pharmtech Inc
TWSE:4119
10.9B TWD
11%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-83%
US
Eli Lilly and Co
NYSE:LLY
756.2B USD
35%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK
44%
US
Johnson & Johnson
NYSE:JNJ
351.2B USD
28%
US
Merck & Co Inc
NYSE:MRK
251.2B USD
34%
CH
Roche Holding AG
SIX:ROG
200.1B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP
21%
CH
Novartis AG
SIX:NOVN
171.5B CHF
31%
US
Pfizer Inc
NYSE:PFE
151.1B USD
22%
Country TW
Market Cap 10.9B TWD
Operating Margin
11%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 756.2B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 2.7T DKK
Operating Margin
44%
Country US
Market Cap 351.2B USD
Operating Margin
28%
Country US
Market Cap 251.2B USD
Operating Margin
34%
Country CH
Market Cap 200.1B CHF
Operating Margin
32%
Country UK
Market Cap 161.8B GBP
Operating Margin
21%
Country CH
Market Cap 171.5B CHF
Operating Margin
31%
Country US
Market Cap 151.1B USD
Operating Margin
22%
No Stocks Found

SCI Pharmtech Inc
Glance View

Market Cap
10.9B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
56.29 TWD
Overvaluation 38%
Intrinsic Value
Price
S

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.3%
=
Operating Profit
159.9m
/
Revenue
1.4B
What is the Operating Margin of SCI Pharmtech Inc?

Based on SCI Pharmtech Inc's most recent financial statements, the company has Operating Margin of 11.3%.